zolbetuximab
astellas
[]
spotlight on zolebetuximab + folfox targeting cldn18.2. found to be superior (pfs/os) to chemo alone in her2 neg advanced gastric cancer. a new standard of care how does it fit in age of immunotherapy?
#gi23
Leader, GI Oncology Unit @wilmotcancer. Researcher in #cachexia, #pancreaticcancer. Girl dad, @notredame alum, tweets opinion not medical advice